BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 38526494)

  • 21. Association of Hospital Public Quality Reporting With Electronic Health Record Medication Safety Performance.
    Holmgren AJ; Bates DW
    JAMA Netw Open; 2021 Sep; 4(9):e2125173. PubMed ID: 34546374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Centralized Program with Stepped Support Increases Adherence to Colorectal Cancer Screening Over 9 Years: a Randomized Trial.
    Green BB; Anderson ML; Cook AJ; Chubak J; Fuller S; Meenan RT; Vernon SW
    J Gen Intern Med; 2022 Apr; 37(5):1073-1080. PubMed ID: 34047921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement.
    ; Davidson KW; Barry MJ; Mangione CM; Cabana M; Caughey AB; Davis EM; Donahue KE; Doubeni CA; Krist AH; Kubik M; Li L; Ogedegbe G; Owens DK; Pbert L; Silverstein M; Stevermer J; Tseng CW; Wong JB
    JAMA; 2021 May; 325(19):1965-1977. PubMed ID: 34003218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delay or Avoidance of Medical Care Because of COVID-19-Related Concerns - United States, June 2020.
    Czeisler MÉ; Marynak K; Clarke KEN; Salah Z; Shakya I; Thierry JM; Ali N; McMillan H; Wiley JF; Weaver MD; Czeisler CA; Rajaratnam SMW; Howard ME
    MMWR Morb Mortal Wkly Rep; 2020 Sep; 69(36):1250-1257. PubMed ID: 32915166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective Cohort study of Predictors of Follow-Up Diagnostic Colonoscopy from a Pragmatic Trial of FIT Screening.
    O'Connor EA; Nielson CM; Petrik AF; Green BB; Coronado GD
    Sci Rep; 2020 Feb; 10(1):2441. PubMed ID: 32051454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic colonoscopy completion after abnormal fecal immunochemical testing and quality of tests used at 8 Federally Qualified Health Centers in Southern California: Opportunities for improving screening outcomes.
    Bharti B; May FFP; Nodora J; Martínez ME; Moyano K; Davis SL; Ramers CB; Garcia-Bigley F; O'Connell S; Ronan K; Barajas M; Gordon S; Diaz G; Ceja E; Powers M; Arredondo EM; Gupta S
    Cancer; 2019 Dec; 125(23):4203-4209. PubMed ID: 31479529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Time to colonoscopy, cancer probability, and precursor lesions in the Danish colorectal cancer screening program.
    Kaalby L; Rasmussen M; Zimmermann-Nielsen E; Buijs MM; Baatrup G
    Clin Epidemiol; 2019; 11():659-667. PubMed ID: 31440102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The compliance rate for the second diagnostic evaluation after a positive fecal occult blood test: A systematic review and meta-analysis.
    Gingold-Belfer R; Leibovitzh H; Boltin D; Issa N; Tsadok Perets T; Dickman R; Niv Y
    United European Gastroenterol J; 2019 Apr; 7(3):424-448. PubMed ID: 31019712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Time to Colonoscopy and Risk of Colorectal Cancer in Patients With Positive Results From Fecal Immunochemical Tests.
    Lee YC; Fann JC; Chiang TH; Chuang SL; Chen SL; Chiu HM; Yen AM; Chiu SY; Hsu CY; Hsu WF; Wu MS; Chen HH
    Clin Gastroenterol Hepatol; 2019 Jun; 17(7):1332-1340.e3. PubMed ID: 30391435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society.
    Wolf AMD; Fontham ETH; Church TR; Flowers CR; Guerra CE; LaMonte SJ; Etzioni R; McKenna MT; Oeffinger KC; Shih YT; Walter LC; Andrews KS; Brawley OW; Brooks D; Fedewa SA; Manassaram-Baptiste D; Siegel RL; Wender RC; Smith RA
    CA Cancer J Clin; 2018 Jul; 68(4):250-281. PubMed ID: 29846947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Comprehensive Primary Care Initiative: Effects On Spending, Quality, Patients, And Physicians.
    Peikes D; Dale S; Ghosh A; Taylor EF; Swankoski K; O'Malley AS; Day TJ; Duda N; Singh P; Anglin G; Sessums LL; Brown RS
    Health Aff (Millwood); 2018 Jun; 37(6):890-899. PubMed ID: 29791190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interventions to Improve Follow-up of Positive Results on Fecal Blood Tests: A Systematic Review.
    Selby K; Baumgartner C; Levin TR; Doubeni CA; Zauber AG; Schottinger J; Jensen CD; Lee JK; Corley DA
    Ann Intern Med; 2017 Oct; 167(8):565-575. PubMed ID: 29049756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.
    Singal AG; Gupta S; Skinner CS; Ahn C; Santini NO; Agrawal D; Mayorga CA; Murphy C; Tiro JA; McCallister K; Sanders JM; Bishop WP; Loewen AC; Halm EA
    JAMA; 2017 Sep; 318(9):806-815. PubMed ID: 28873161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association Between Time to Colonoscopy After a Positive Fecal Test Result and Risk of Colorectal Cancer and Cancer Stage at Diagnosis.
    Corley DA; Jensen CD; Quinn VP; Doubeni CA; Zauber AG; Lee JK; Schottinger JE; Marks AR; Zhao WK; Ghai NR; Lee AT; Contreras R; Quesenberry CP; Fireman BH; Levin TR
    JAMA; 2017 Apr; 317(16):1631-1641. PubMed ID: 28444278
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inadequate Utilization of Diagnostic Colonoscopy Following Abnormal FIT Results in an Integrated Safety-Net System.
    Issaka RB; Singh MH; Oshima SM; Laleau VJ; Rachocki CD; Chen EH; Day LW; Sarkar U; Somsouk M
    Am J Gastroenterol; 2017 Feb; 112(2):375-382. PubMed ID: 28154400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic Survival Associated With Left-Sided vs Right-Sided Colon Cancer: A Systematic Review and Meta-analysis.
    Petrelli F; Tomasello G; Borgonovo K; Ghidini M; Turati L; Dallera P; Passalacqua R; Sgroi G; Barni S
    JAMA Oncol; 2017 Feb; 3(2):211-219. PubMed ID: 27787550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Time to Colonoscopy after Positive Fecal Blood Test in Four U.S. Health Care Systems.
    Chubak J; Garcia MP; Burnett-Hartman AN; Zheng Y; Corley DA; Halm EA; Singal AG; Klabunde CN; Doubeni CA; Kamineni A; Levin TR; Schottinger JE; Green BB; Quinn VP; Rutter CM;
    Cancer Epidemiol Biomarkers Prev; 2016 Feb; 25(2):344-50. PubMed ID: 26843520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Pioneer accountable care organization model: improving quality and lowering costs.
    Pham HH; Cohen M; Conway PH
    JAMA; 2014 Oct 22-29; 312(16):1635-6. PubMed ID: 25229477
    [No Abstract]   [Full Text] [Related]  

  • 39. Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies.
    Inadomi JM; Vijan S; Janz NK; Fagerlin A; Thomas JP; Lin YV; Muñoz R; Lau C; Somsouk M; El-Nachef N; Hayward RA
    Arch Intern Med; 2012 Apr; 172(7):575-82. PubMed ID: 22493463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Racial disparities in stage-specific colorectal cancer mortality rates from 1985 to 2008.
    Robbins AS; Siegel RL; Jemal A
    J Clin Oncol; 2012 Feb; 30(4):401-5. PubMed ID: 22184373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.